Entry |
|
Name |
Remogliflozin etabonate (USAN/INN) |
Formula |
C26H38N2O9
|
Exact mass |
522.2577
|
Mol weight |
522.5879
|
Structure |

|
Class |
|
Efficacy |
Antidiabetic, SGLT-2 inhibitor |
Comment |
Phlorizin derivative
Treatment of type 2 diabetes
|
Target |
|
Interaction |
|
Brite |
Drug groups [BR:br08330]
Antidiabetic agent
DG02044 Hypoglycemic agent
DG01794 SGLT2 inhibitor
D10055 Remogliflozin etabonate
Target-based classification of drugs [BR:br08310]
Transporters
Solute carrier family
SLC5
SLC5A2 (SGLT2)
D10055 Remogliflozin etabonate (USAN/INN)
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 37
1 C1y C 15.8200 -24.7100
2 C1y C 15.8200 -26.1100
3 C1y C 17.0100 -26.8100
4 C1y C 18.2700 -26.1100
5 O2x O 18.2700 -24.7100
6 C1y C 17.0100 -24.0100
7 C1b C 17.0100 -22.6100
8 O1a O 14.6300 -26.8100
9 O2a O 19.4600 -26.8100
10 O7a O 15.8200 -21.9100
11 O1a O 14.6300 -24.0100
12 O1a O 17.0100 -28.2100
13 C7a C 15.8200 -20.5100
14 O6a O 17.0100 -19.8100
15 O7a O 14.6300 -19.8100
16 C8y C 20.6500 -26.1100
17 C8y C 21.7700 -26.9500
18 C8y C 22.8900 -26.1800
19 N4y N 22.4700 -24.8500
20 N5x N 21.1400 -24.8500
21 C1b C 13.4400 -20.5100
22 C1a C 12.2500 -19.8100
23 C1b C 21.7700 -28.3500
24 C8y C 22.9600 -29.1200
25 C8x C 22.9600 -30.5200
26 C8x C 24.1500 -31.2200
27 C8y C 25.3400 -30.5900
28 C8x C 25.3400 -29.1200
29 C8x C 24.2200 -28.4200
30 O2a O 26.6000 -31.2900
31 C1c C 27.7900 -30.5200
32 C1a C 28.9800 -31.2200
33 C1a C 27.7900 -29.1200
34 C1a C 24.0800 -26.8800
35 C1c C 23.6600 -24.1500
36 C1a C 24.8500 -24.8500
37 C1a C 23.6600 -22.7500
BOND 39
1 1 2 1
2 2 3 1
3 3 4 1
4 4 5 1
5 5 6 1
6 1 6 1
7 6 7 1 #Up
8 2 8 1 #Up
9 4 9 1 #Up
10 7 10 1
11 1 11 1 #Down
12 3 12 1 #Down
13 10 13 1
14 13 14 2
15 13 15 1
16 9 16 1
17 16 17 1
18 17 18 2
19 18 19 1
20 19 20 1
21 16 20 2
22 15 21 1
23 21 22 1
24 17 23 1
25 23 24 1
26 24 25 2
27 25 26 1
28 26 27 2
29 27 28 1
30 28 29 2
31 24 29 1
32 27 30 1
33 30 31 1
34 31 32 1
35 31 33 1
36 18 34 1
37 19 35 1
38 35 36 1
39 35 37 1
|